Cargando…
R‐spondin‐3 is an oncogenic driver of poorly differentiated invasive breast cancer
R‐spondins (RSPOs) are influential signaling molecules that promote the Wnt/β‐catenin pathway and self‐renewal of stem cells. Currently, RSPOs are emerging as clinically relevant oncogenes, being linked to cancer development in multiple organs. Although this has instigated the rapid development and...
Autores principales: | ter Steege, Eline J, Boer, Mandy, Timmer, Nikki C, Ammerlaan, Carola ME, Song, Ji‐Ying, Derksen, Patrick WB, Hilkens, John, Bakker, Elvira RM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825844/ https://www.ncbi.nlm.nih.gov/pubmed/36106661 http://dx.doi.org/10.1002/path.5999 |
Ejemplares similares
-
The role of R-spondin proteins in cancer biology
por: ter Steege, Eline J., et al.
Publicado: (2021) -
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice
por: ter Steege, Eline J., et al.
Publicado: (2022) -
RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis
por: Hilkens, John, et al.
Publicado: (2017) -
IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation
por: Ikink, Gerjon J., et al.
Publicado: (2016) -
Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance
por: Ikink, Gerjon J., et al.
Publicado: (2018)